Skip to main content
. 2016 Jan 13;9:1–9. doi: 10.2147/CEG.S92714

Table 3.

Characteristics of men with and without nonalcoholic fatty liver disease

Variables NAFLD patients
(N=59)
Controls
(N=22)
P-value
Age (years) 51±11 55±11 0.100
Waist circumference (cm) 106±12 92±10 <0.001
BMI (kg/m2) 30±4.7 26±4 <0.001
Smoking (%) 32.7 27.8 0.695
eGFR (mL/min/1.73 m2) 80±2 81±2 0.802
Hypertension (%) 76.3 86.4 0.321
Office SBP (mmHg) 153±19 149±13 0.290
Office DBP (mmHg) 93±13 91±8 0.526
24-hour mean SBP (mmHg) 135±13 131±10 0.168
24-hour mean DBP (mmHg) 84±11 83±7 0.716
Daytime mean SBP (mmHg) 141±14 137±9 0.300
Daytime mean DBP (mmHg) 89±11 88±7 0.816
Nighttime mean SBP (mmHg) 122±16 119±12 0.316
Nighttime mean DBP (mmHg) 73±11 71±8 1.000
Morning mean SBP (mmHg) 133±15 131±13 0.549
Morning mean DBP (mmHg) 84±11 83±7 0.813
White-coat hypertension (%) 11.9 12.5 0.293
AST (IU/L) 25±11 20±7 0.097
ALT (IU/L) 39±31 32±36 0.439
GGT (IU/L) 30±18 21±12 0.038
ALP (IU/L) 93±55 78±44 0.796
CHOL (mg/dL) 220±39 212±37 0.265
LDL (mg/dL) 148±46 136±30 0.205
HDL (mg/dL) 49±16 56±16 0.147
TRIGL (mg/dL) 138±75 109±50 0.127
Hs-CRP (mg/dL) 1.25±1.75 0.74±0.69 0.314
GLU (mg/L) 99±16 93±8 0.112

Notes: Data are presented as mean ± standard deviation. Upper reference limits are 45 IU/L for AST, 45 IU/L for ALT, 55 IU/L for GGT, 150 IU/L for ALP, 200 mg/dL for CHOL, 140 mg/dL for LDL, 160 mg/dL for TRIGL, 5 mg/L for Hs-CRP, and 110 mg/dL for GLU in our laboratory. Lower reference limit is 35 mg/dL for HDL in our laboratory.

Abbreviations: NAFLD, nonalcoholic fatty liver disease; eGFR, estimated glomerular filtration rate; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma glutamyl transpeptidase; ALP, alkaline phosphatase; CHOL, cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TRIGL, triglycerides; Hs-CRP, high-density c-reactive protein; GLU, glucose serum fast.